{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:37:50Z","timestamp":1788975470900,"version":"build-2803163510"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thegreenjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.radonc.2016.10.024","type":"journal-article","created":{"date-parts":[[2016,11,16]],"date-time":"2016-11-16T14:15:02Z","timestamp":1479305702000},"page":"130-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["Central liver toxicity after SBRT: An expanded analysis and predictive nomogram"],"prefix":"10.1016","volume":"122","author":[{"given":"Diego A.S.","family":"Toesca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan C.","family":"Osmundson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie von","family":"Eyben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny L.","family":"Shaffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert C.","family":"Koong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel T.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2016.10.024_b0005","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.ijrobp.2005.01.002","article-title":"A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases","volume":"62","author":"Schefter","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.10.024_b0010","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1080\/02841860600904870","article-title":"Interim analysis of a prospective phase I\/II trial of SBRT for liver metastases","volume":"45","author":"Kavanagh","year":"2006","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2016.10.024_b0015","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1200\/JCO.2007.14.3529","article-title":"Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"26","author":"Tse","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2016.10.024_b0020","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1200\/JCO.2008.19.6329","article-title":"Multi-institutional phase I\/II trial of stereotactic body radiation therapy for liver metastases","volume":"27","author":"Rusthoven","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2016.10.024_b0025","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s12094-010-0492-x","article-title":"Phase I feasibility trial of stereotactic body radiation therapy for primary hepatocellular carcinoma","volume":"12","author":"C\u00e1rdenes","year":"2010","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.radonc.2016.10.024_b0030","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.ijrobp.2009.08.020","article-title":"Dose\u2013escalation study of single-fraction stereotactic body radiotherapy for liver malignancies","volume":"78","author":"Goodman","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.10.024_b0035","doi-asserted-by":"crossref","first-page":"e447","DOI":"10.1016\/j.ijrobp.2011.04.011","article-title":"Stereotactic body radiotherapy for primary hepatocellular carcinoma","volume":"81","author":"Andolino","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.10.024_b0040","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1002\/cncr.25997","article-title":"Stereotactic body radiotherapy for colorectal liver metastases: a pooled analysis","volume":"117","author":"Chang","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2016.10.024_b0045","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1016\/S1470-2045(12)70510-7","article-title":"Stereotactic body radiotherapy for oligometastases","volume":"14","author":"Tree","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2016.10.024_b0050","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/1748-717X-8-250","article-title":"High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinoma","volume":"8","author":"Jang","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2016.10.024_b0055","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.radonc.2015.04.006","article-title":"Stereotactic body radiation therapy as an ablative treatment for inoperable hepatocellular carcinoma","volume":"115","author":"Huertas","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2016.10.024_b0060","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1200\/JCO.2015.61.4925","article-title":"Outcomes after stereotactic body radiotherapy or radiofrequency ablation for hepatocellular carcinoma","volume":"34","author":"Wahl","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2016.10.024_b0065","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.30008","article-title":"Phase 2 study of stereotactic body radiotherapy and optional transarterial chemoembolization for solitary hepatocellular carcinoma not amenable to resection and radiofrequency ablation","author":"Takeda","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2016.10.024_b0070","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijrobp.2005.11.034","article-title":"Prediction of radiation-induced liver disease by Lyman normal-tissue complication probability model in three-dimensional conformal radiation therapy for primary liver carcinoma","volume":"65","author":"Xu","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.10.024_b0075","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ijrobp.2005.12.031","article-title":"Radiation-induced liver disease in three-dimensional conformal radiation therapy for primary liver carcinoma: the risk factors and hepatic radiation tolerance","volume":"65","author":"Liang","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.10.024_b0080","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/1748-717X-8-249","article-title":"Radiation-induced liver disease after stereotactic body radiotherapy for small hepatocellular carcinoma: clinical and dose-volumetric parameters","volume":"8","author":"Jung","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2016.10.024_b0085","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0140-6736(89)91015-5","article-title":"Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis","volume":"2","author":"Bruix","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2016.10.024_b0090","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0140-6736(81)90585-7","article-title":"Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan","volume":"2","author":"Beasley","year":"1981","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.radonc.2016.10.024_b0095","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1002\/1097-0142(19900401)65:7<1607::AID-CNCR2820650726>3.0.CO;2-2","article-title":"Silent cirrhosis in patients with hepatocellular carcinoma. Implications for screening in high-incidence and low-incidence areas","volume":"65","author":"Zaman","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2016.10.024_b0100","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0360-3016(02)02846-8","article-title":"Analysis of radiation-induced liver disease using the Lyman NTCP model","volume":"53","author":"Dawson","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.10.024_b0105","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.ijrobp.2009.06.092","article-title":"Radiation-associated liver injury","volume":"76","author":"Pan","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.10.024_b0110","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.prro.2015.04.011","article-title":"Stereotactic body radiation therapy and central liver toxicity: a case report","volume":"5","author":"Shaffer","year":"2015","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2016.10.024_b0115","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ijrobp.2014.11.028","article-title":"Predictors of toxicity associated with stereotactic body radiation therapy to the central hepatobiliary tract","volume":"91","author":"Osmundson","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2016.10.024_b0120","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.suc.2008.07.001","article-title":"Biliary anatomy and embryology","volume":"88","author":"Vakili","year":"2008","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.radonc.2016.10.024_b0125","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejrad.2010.11.007","article-title":"Diameters of the common bile duct in adults and postcholecystectomy patients: a study with 64-slice CT","volume":"81","author":"Senturk","year":"2012","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.radonc.2016.10.024_b0130","doi-asserted-by":"crossref","first-page":"306","DOI":"10.5009\/gnl.2009.3.4.306","article-title":"Determination of diameter and angulation of the normal common bile duct using multidetector computed tomography","volume":"3","author":"Park","year":"2009","journal-title":"Gut Liver"},{"key":"10.1016\/j.radonc.2016.10.024_b0135","unstructured":"National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) version 4.03: June 14, 2010. U.S. Department of Health and Human Services; National Institutes of Health; National Cancer Institute."},{"key":"10.1016\/j.radonc.2016.10.024_b0140","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","article-title":"Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach \u2013 the ALBI grade","volume":"33","author":"Johnson","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2016.10.024_b0145","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/jrr\/rru130","article-title":"Survival outcomes after stereotactic body radiotherapy for 79 Japanese patients with hepatocellular carcinoma","volume":"56","author":"Yamashita","year":"2015","journal-title":"J Radiat Res"},{"key":"10.1016\/j.radonc.2016.10.024_b0150","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/s00432-015-1929-y","article-title":"The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT)","volume":"141","author":"Scorsetti","year":"2015","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.radonc.2016.10.024_b0155","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/jso.24128","article-title":"Stereotactic body radiation therapy for small primary or recurrent hepatocellular carcinoma in 132 Chinese patients","volume":"113","author":"Su","year":"2016","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.radonc.2016.10.024_b9000","doi-asserted-by":"crossref","DOI":"10.1016\/j.prro.2016.10.003","article-title":"Assessment of hepatic function decline after stereotactic body radiation therapy for primary liver cancer","author":"Toesca","year":"2016","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2016.10.024_b0160","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.gie.2010.07.036","article-title":"Covered versus uncovered self-expandable nitinol stents in the palliative treatment of malignant distal biliary obstruction: results from a randomized, multicenter study","volume":"72","author":"Kullman","year":"2010","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.radonc.2016.10.024_b0165","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1148\/radiology.156.3.4023221","article-title":"Biliary stent endoprosthesis: analysis of complications in 113 patients","volume":"156","author":"Mueller","year":"1985","journal-title":"Radiology"},{"key":"10.1016\/j.radonc.2016.10.024_b0170","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S1051-0443(93)71970-3","article-title":"Complications of percutaneously inserted biliary Wallstents","volume":"4","author":"Stoker","year":"1993","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.radonc.2016.10.024_b0175","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00270-001-0030-x","article-title":"Nitinol stents for palliative treatment of malignant obstructive jaundice: should we stent the sphincter of Oddi in every case?","volume":"24","author":"Hatzidakis","year":"2001","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.radonc.2016.10.024_b0180","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.3748\/wjg.v22.i26.6065","article-title":"Impact of biliary stent-related events in patients diagnosed with advanced pancreatobiliary tumours receiving palliative chemotherapy","volume":"22","author":"Lamarca","year":"2016","journal-title":"World J Gastroenterol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814016343766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814016343766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T17:52:21Z","timestamp":1536256341000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814016343766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S0167814016343766"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2016.10.024","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Central liver toxicity after SBRT: An expanded analysis and predictive nomogram","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2016.10.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}